ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Casual dining is turning a corner. Chili's posted an eye-catching 8.6% same-store sales gain, signaling a broader shi...
Tilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
In today’s Morning Minute, Circle earnings take center stage as crypto markets rally. Stablecoins anchor liquidity wh...
Fannie Freddie Boldly Remove the 620 FICO floor marks a historic change in conventional lending. This article explain...
As volatility remains a theme, smart investors are looking for growth stocks first half opportunities with real catal...
A new government estimate links weekly economic losses from the Israel-Hamas/Iran front to alert levels, while Bitcoi...
Liberty Formula One stock trades around $83 after a strong Q4. Jim Cramer flags the pullback as a terrific buying opp...
The nobel laureate joseph stiglitz warns that AI’s hunger for internet chatter could degrade the data powering market...
Spring 2026 opens with a housing market shaped by jobs data, energy prices, and mortgage-rate swings. This article ou...
The NYC Council greenlights a 72-story Brooklyn tower with 1,263 units, a quarter permanently affordable. Constructio...
XRPL developers are testing Zero-Knowledge Proofs to hide transaction details on the XRP Ledger while preserving audi...